Swifties shower 13-year-old Bucks County girl with love after brain cancer diagnosis
13-year-old Lily Tomlinson was diagnosed with DIGP, a terminal brain cancer.
Taylor Swift fans found out on social media and began to send gifts.
Lily is hoping to meet Taylor Swift.
PIPERSVILLE, Pa. - The ultimate Taylor Swift fan is receiving a lot of love from other Swifties in her time of need. Lily Tomlinson is living with terminal cancer and her fellow Taylor Swift fans are making sure the Bucks County teen feels the outpouring support from around the country.
The backstory
Doctors diagnosed Lily Tomlinson in December of last year with DIPG, which is a terminal brain cancer. She finished radiation at Children's Hospital Of Philadelphia and is now at home in Bucks County. Lily and her mom are Taylor Swift fans. Swifties learned of Lily and have surrounded her with gifts and love.
What they're saying
"It's really great. It is amazing. I was diagnosed with something bad, and I thought the rest of my life was going to be bad," said Lily Tomlinson until boxes of Taylor Swift stuff began to arrive. Now almost anything T-Swift you can find in her home.
"Then mom gave me these packages and I said, 'What are these?' And it is like everyone is supporting me through the Taylor Swift merch," she said. "They've lately been sending books, stickers and bracelets. I really appreciate all the bracelets because I like to wear them."
After she was diagnosed with brain cancer, her mom, Kelsey, immediately wanted to do something to help her little girl.
"I was thinking what radiation was gonna look like and silly things like her having a lap blanket, her having a beanie hat. In case she lost hair and wanting to bring some happiness," said Kelsey Tomlinson. She reached out to a Swifty crafting group on Facebook to ask for help with comfort items for her daughter. She had no idea what would come.
"They are overwhelmingly kind and they are really just overwhelming - a genuinely caring group of people," said Kelsey about Swifties.
"We were asked very kindly by the post office to start coming every day because the box was full and then their back room was getting full," she laughed.
Big picture view
Kelsey says Lily finished radiation, is discharged from CHOP and now back at home where she wanted to be and is most comfortable.
"While every case is different, typically with this diagnosis the prognosis is eight months to a year," said Kelsey.
Lily is brave and open about her cancer but is focusing on the things she enjoys, like reading books, listening to Taylor Swift and being outside on the acres of land they live on in Bucks County. She is also happy to finally be able to eat on her own again.
"I like sushi and donuts. Wawa mac n cheese. Wawa mac n cheese is the lightest, fluffiest thing," said Lily. She says her family keeps her going along with Swifties who will stop at nothing to make her feel comforted and even more loved.
"It's helped me realize that other people are going through what I'm going through and that there are people there to help me," said Lily.
What you can do
The family has a GoFundMe and the hashtag #SwiftiesforLily which they hope gets the attention of Taylor Swift.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
All the benefits of having a G&T over a glass of wine
If you're going to indulge in a drink or two, whether on holiday or in a pub garden, a gin and tonic could be the best option for your health. As a registered nutritionist, Sophie Trotman is bound to repeat the words that we are all so used to hearing: 'I would always recommend that you don't drink at all, or at least lower the amount that you drink,' she says. 'Wines can be quite sugary and contain a lot of sulphates,' Trotman says, which can wreak havoc on your digestive system, while beers 'are high in carbohydrates' and can cause your blood sugar to spike. The heroic G&T, meanwhile, is a drink that 'I often recommend to my clients if they don't want to cut out alcohol entirely,' says Trotman. 'The calories and sugar in a single gin with a light tonic are as low as you're going to get.' This will be welcome news to many. The majority of people in Britain now prefer to drink gin and tonic with friends rather than cups of builders' tea, according to spirit brand Bacardi's cocktail trend report, and the UK constitutes the world's biggest market for gin. So what are the benefits of swapping your regular pint or glass of wine for a G&T? The health benefits of a G&T 1. Fewer calories than beer and wine One shot of gin will provide you with around 50 calories, compared with about 130 calories in a medium glass of red or white wine or the 200-300 calories in a pint of beer. A 200ml serving of light tonic to mix your drink will come in at around 30 calories, keeping a health-conscious G&T under 100 calories to a glass. The average British man drinks 17.6 units of alcohol every week, according to NHS data, the equivalent of eight to nine pints of lager (with beer still being the drink consumed most frequently by men in the UK). Drinking the same number of single-measure G&Ts each week – though it is not recommended that any adult consumes more than 14 units of alcohol in this timeframe – would mean cutting around 900 'empty' calories from your diet and losing a stone within a year. Meanwhile, women who switch from the average nine units or four medium glasses of wine per week to single G&Ts would drink 120 fewer calories. This might not sound like much, but tweaks like this can make all the difference in limiting your party-season weight gain. At this time of year when the units we consume will likely outpace our average for the year, 'a gin and tonic is definitely a better option to manage your weight,' Trotman says. 2. Less sugar and carbs than other contenders A single shot of gin contains zero grams of sugar, as well as no carbohydrates. This is one of the reasons that gin is often the drink of those on a ketogenic diet, as it is less likely to knock your body out of its fat-burning state (though all alcohol will make it harder for your liver to process food). Aside from leading to weight gain, drinking any beverage that has a high carbohydrate content – like lager, with 10-15 grams of carbs to a pint, or cider which has as much as 40 grams a glass – can cause uncomfortable bloating and an upset stomach. A no-carb drink such as gin 'will have less of an impact on your blood sugar levels too,' Trotman says, another factor that makes it a better option for keeping your waistline static (and making sure that you've still got some energy the morning after). And while vodkas and rums typically come mixed in fizzy, sugary drinks, the sugar in a slimline tonic typically comes in at around 7.6 grams per 200ml glass, compared with the 21.2g in 200ml of full-fat Coca Cola. Light rather than diet tonic is ideal with your gin as 'diet tonic will be full of artificial sweeteners that can worsen your health in the long term,' Trotman says. 'So if you're having a few, always opt for a light version and a single shot.' 3. A boost from juniper berries and garnishes Gin is made by brewing a neutral-tasting grain with juniper berries and other botanicals such as lemon peel, coriander seeds, cardamom or thyme. Juniper berries contain flavonoids as well as large amounts of vitamin C, which can improve circulation and help ward off colds, and antioxidants which promote skin regeneration. These berries can also speed up your digestive system and soothe inflammation. While the amount of these goodies left over in a single serving of gin is likely 'negligible', Trotman says, gin can also be infused with ingredients that up its health benefits: some kinds on the market have been paired with large volumes of fruit juice for added vitamin C, while some have been specifically blended to provide micronutrients as well as collagen. Others are brewed with extra juniper berries. G&Ts are also easy to make and serve creatively. A quick health tip is just to 'eat the slice of orange that comes with your drink, because every little does help,' Trotman says, or at home 'you could mix in some cranberry juice for antioxidants or add some blueberries for helpful polyphenols'. 4. Easier to drink in moderation The versatility of a gin and tonic is a major reason why Sophie Trotman recommends it to her clients. Along with a light tonic, 'you can add a lot of ice to make it a long drink that you're able to keep sipping over a longer period,' reducing the total amount of alcohol you drink in the course of an evening. The reduced sugar and artificial sweeteners involved meanwhile will make it easier to stop at just a few, turning down the dial on your cravings and helping you to call it a night earlier. Unlike wine, the leftover bottle of which can call from the fridge on a Monday evening, a G&T takes more effort to make and so it becomes 'easier to have days off,' Trotman says. 'It's also very easy to alternate your G&Ts with glasses of water, which you'll thank yourself for the next day,' Trotman says. For those looking to cut down there are other benefits too. 'It shouldn't be a concern, but if you start on G&Ts and switch to a non-alcoholic version later in the night, there will be no label on your glass and so no peer pressure from anyone else to keep going.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
CBS News
3 days ago
- CBS News
Zoo strep outbreak pauses intakes at Stanislaus Animal Services as vet shortage, clinic gaps persist
A contagious respiratory illness known as zoo strep has forced Stanislaus Animal Services to halt all stray animal intakes, as shelter staff work to deep-clean the facility and separate exposed dogs. "We're having to empty out sections at a time," said SASA Director Lily Yap. "Those areas are essentially on hold while we perform the deep clean." There's no timeline for when intakes will resume. But the outbreak is just one part of a larger challenge. In 2024, the Joint Powers Authority Board, made up of six government partners, including Stanislaus County and five cities, approved more than $500,000 for a new low-cost spay and neuter site, known as the Love Clinic. The idea was to make the clinic self-sustaining. Instead, it's barely running. "The original expectation was that it would fund itself," Yap said. "But the biggest challenge is being able to fill that veterinarian position." Without a vet, the clinic offers only a handful of appointments each week. This isn't the first time public veterinary services have hit a wall. In 2023, a Stanislaus County Civil Grand Jury report revealed that SASA's request for a mobile clinic was denied by the JPA board, which later reclaimed nearly $400,000 in unused funds. "Our partners have the option to take those funds back," Yap said, "or put it toward the next year's budget." With rising stray numbers, a shelter-wide disease outbreak, and no full-time vet in sight, Yap says the agency is relying on fosters, volunteers, and a September budget reassessment to try to fill the gap.
Yahoo
3 days ago
- Yahoo
J&J tests direct CAR-T marketing with first Carvykti ad
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Available cell therapies for cancer aren't easy treatments to receive. Personalized to each patient, the drugs are complicated and time-consuming to manufacture, and must be delivered and administered on an exacting schedule. And because they come with serious risks, patients need to remain close to the hospital where they were treated for weeks of monitoring. All of these characteristics make Johnson & Johnson's choice to roll out direct-to-consumer advertising for Carvykti, a cell therapy it sells for the blood cancer multiple myeloma, somewhat unexpected. The ad, which will air on streaming services like YouTube, Paramount and Roku, is J&J's first for the drug and a rare instance of DTC marketing for this kind of cell therapy, known as CAR-T. According to June Lanoue, J&J's head of U.S. hematology, the company aims to raise awareness about cell therapy, particularly among patients who may not be receiving care from the kind of specialized academic centers where CAR-T is often given. Carvykti is currently approved in the U.S. to treat multiple myeloma in patients whose disease either relapsed or becomes resistant to treatment after an initial round of therapy. Another CAR-T therapy, called Abecma and sold by Bristol Myers Squibb, is also cleared for this use, but only after two or more prior lines of treatment. Among these 'relapsed, refractory' patients, about half are treated at community oncology centers, Lanoue said. 'The actual awareness level of these options is very low,' she added. 'In the community, if they're not able to get it, doctors are not talking about and therefore they don't have visibility to having a new option.' J&J's choice to advertise is a signal of confidence in its ability to manufacture enough Carvykti to meet any rise in demand. Early on in the drug's launch, production challenges forced the company to limit orders from treating centers. (Bristol Myers ran into similar issues.) 'We feel very confident around production,' said Lanoue. Treatment sites can 'order Carvykti without any constraint.' The launch of the ad is also well-timed, as it comes several weeks after the Food and Drug Administration took steps to improve access to CAR-T treatment broadly. The agency eased some side effect reporting requirements and lessened the time it mandates patients stay near their treating facility for monitoring. It also said patients could resume driving or operating machinery sooner after treatment than previously prescribed. 'We think it will give more opportunity to more patients who [live at] a little bit further distance to be able to receive Carvykti,' Lanoue said. J&J's 120-second ad introduces a composite patient, 'Marvin,' and describes the heavy burden of injections and pills typically used to control multiple myeloma. Carvykti, by contrast, is a one-time infusion that can deliver lasting benefits in some. Recent follow-up data from an early study of around 100 patients treated with Carvykti showed that, at five years, one-third had not yet experienced disease progression. A story published in June by The New York Times that highlighted these findings led to more patients requesting information about Carvykti, according to Lanoue. J&J did not share how much it's spending on this marketing campaign, but Lanoue said it is 'significantly less' than what a pharmaceutical company would typically spend on a regular TV advertisement. 'This is not a share of voice play; this is ultra targeted,' she added. Sales of Carvykti reached $439 million in the three months between April and June. The company expects peak annual sales to eventually eclipse $5 billion. Editor's note: After this story was published, J&J updated the list of streaming services where its ad will appear and removed Hulu for the time being. Recommended Reading FDA takes major step to ease access to CAR-T therapy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
